BIBF 1120 and RAD001 in Solid Tumors - Phase I
NCT01349296
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Everolimus + BIBF 1120
Sponsor
University of Cologne
Collaborators
[object Object]